Skip to main content

PLEASE NOTE: For everyone’s safety, Fasken recommends anyone on-site at our Canadian offices be familiar with the COVID-19 recommendations in place which may include one or more of the following: social distancing, hand sanitizing, wearing a mask in common areas and proof of full vaccination. These measures apply to lawyers, staff, clients, service providers and other visitors.

Client Work

Chromos sells ACE System technology to Glaxo Group

Fasken
Reading Time 1 minute read Subscribe

Overview

Client

Chromos Molecular Systems

On November 14, 2007, Chromos Molecular Systems Inc. announced that it had completed the sale of its ACE System technology to Glaxo Group Limited. A portion of the proceeds from this sale transaction was used to fund the $1.1 million required to be paid under the terms of the creditor proposal announced in the Company's August 28, 2007 press release. The remaining proceeds provide additional working capital to fund ongoing operations. Chromos was advised by a team from Fasken Martineau comprised of Iain Mant, Roger Kuypers, Marcel Peerson and David Ford.

Team

    Subscribe

    Receive email updates from our team

    Subscribe